Vericel Corp- 詳細介紹、公司背景、業務範圍、財務數據以及市場表現

關於 Vericel Corp 公司

Vericel Corporation 是一家完全整合的商業階段生物製藥公司。該公司爲運動醫學和嚴重燒傷護理市場提供先進療法。它在美國銷售三種產品。MACI（豬膠原膜上的自體培養軟骨細胞）是一種自體細胞化支架產品，用於修復成人有症狀的、一個或多個全層膝關節軟骨缺損（無論是否涉及骨骼）。Epicel（培養的自體表皮移植）是一種永久性皮膚替代品，用於治療深層真皮或全層燒傷面積大於或等於全身表面積 30% 的患者。該公司還持有 NexoBrid（anacaulase-bcdb）的北美權利許可，這是一種含有蛋白水解酶的生物孤兒產品，用於去除成人深層部分厚度和/或全層燒傷的焦痂。

Vericel Corp簡介



公司代碼VCEL

公司名稱Vericel Corp

上市日期Feb 04, 1997

CEOMr. Dominick C. Colangelo

員工數量357

證券類型Ordinary Share

年結日Feb 04

公司地址64 Sidney St

城市CAMBRIDGE

上市交易所NASDAQ Global Market Consolidated

國家United States of America

郵編02139

電話17349305555

網址https://vcel.com/

公司代碼VCEL

上市日期Feb 04, 1997

CEOMr. Dominick C. Colangelo

Vericel Corp公司高管



名稱

名稱/職務

職務

持股

持股變動

Mr. Dominick C. Colangelo

President, Chief Executive Officer, Director

260.28K

--

Dr. Jonathan Mark Hopper

Chief Medical Officer

66.21K

--

Mr. Alan L. Rubino

Independent Director

45.99K

+7.48%

Dr. Paul K. Wotton, Ph.D.

Independent Director

30.60K

+11.68%

Dr. Robert L. Zerbe, M.D.

Independent Chairman of the Board

29.80K

+12.03%

Mr. Michael Halpin

Chief Operating Officer

15.63K

+2.77%

Mr. Kevin F. Mclaughlin

Independent Director

15.10K

--

Ms. Lisa Wright

Independent Director

12.65K

+33.86%

Mr. Sean C. Flynn

Chief Legal Officer

971.00

+105.29%

Ms. Heidi M. Hagen

Independent Director

--

名稱

名稱/職務

職務

持股

持股變動

Mr. Dominick C. Colangelo

President, Chief Executive Officer, Director

260.28K

--

Dr. Jonathan Mark Hopper

Chief Medical Officer

66.21K

--

Mr. Alan L. Rubino

Independent Director

45.99K

+7.48%

Dr. Paul K. Wotton, Ph.D.

Independent Director

30.60K

+11.68%

Dr. Robert L. Zerbe, M.D.

Independent Chairman of the Board

29.80K

+12.03%

Mr. Michael Halpin

Chief Operating Officer

15.63K

+2.77%

收入明細

單位: USD更新時間: 10月6日週一

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

業務USD

名稱

營收

佔比

MACI

53.46M

84.53%

Epicel

8.61M

13.62%

NexoBrid

1.17M

1.85%

地區USD

名稱

營收

佔比

United States

63.24M

100.00%

業務

地區

業務USD

名稱

營收

佔比

MACI

53.46M

84.53%

Epicel

8.61M

13.62%

NexoBrid

1.17M

1.85%

股東統計

更新時間: 8月15日週五

持股股東

股東類型

持股股東

佔比

BlackRock Institutional Trust Company, N.A.

13.89%

The Vanguard Group, Inc.

7.04%

Brown Capital Management, LLC

5.57%

State Street Investment Management (US)

4.83%

Conestoga Capital Advisors, LLC

4.31%

其他

64.36%

持股股東

佔比

BlackRock Institutional Trust Company, N.A.

13.89%

The Vanguard Group, Inc.

7.04%

Brown Capital Management, LLC

5.57%

State Street Investment Management (US)

4.83%

Conestoga Capital Advisors, LLC

4.31%

其他

64.36%

股東類型

持股股東

佔比

Investment Advisor

65.78%

Investment Advisor/Hedge Fund

38.20%

Pension Fund

2.78%

Research Firm

2.56%

Hedge Fund

1.37%

Bank and Trust

1.08%

Individual Investor

1.06%

Insurance Company

0.10%

Sovereign Wealth Fund

0.05%

機構持股



更新時間: 10月1日週三

報告期間

機構數

持股數

持股佔比

持股變動

2025Q3

543

56.93M

112.82%

-720.71K

2025Q2

541

57.26M

113.48%

+428.24K

2025Q1

559

55.34M

109.94%

-1.25M

2024Q4

543

54.07M

108.22%

-1.11M

2024Q3

519

52.64M

107.39%

-2.94M

2024Q2

509

52.53M

108.12%

-3.27M

2024Q1

499

52.78M

109.13%

-3.92M

2023Q4

473

53.52M

112.14%

-4.39M

2023Q3

463

53.25M

111.77%

-4.17M

2023Q2

465

51.63M

108.55%

-6.73M

股東持股明細



名稱

持股數

佔比

持股變動

變動比例

公告日期

BlackRock Institutional Trust Company, N.A.

7.01M

13.89%

-253.88K

-3.50%

Jun 30, 2025

The Vanguard Group, Inc.

3.55M

7.04%

+69.96K

+2.01%

Jun 30, 2025

Brown Capital Management, LLC

2.81M

5.57%

-70.14K

-2.43%

Jun 30, 2025

State Street Investment Management (US)

2.44M

4.83%

-1.72K

-0.07%

Jun 30, 2025

Conestoga Capital Advisors, LLC

2.46M

4.88%

+401.99K

+19.50%

Jun 30, 2025

Fidelity Management & Research Company LLC

1.97M

3.91%

-216.21K

-9.88%

Jun 30, 2025

Geneva Capital Management LLC

1.78M

3.54%

+419.18K

+30.69%

Jun 30, 2025

Invesco Advisers, Inc.

1.77M

3.51%

-214.40K

-10.80%

Jun 30, 2025

Congress Asset Management Company, LLP

1.74M

3.45%

+265.61K

+17.99%

Jun 30, 2025

GW&K Investment Management, LLC

1.41M

2.8%

-17.89K

-1.25%

Jun 30, 2025

持股ETF



更新時間: 10月6日週一

機構名稱

佔比

Invesco S&P SmallCap Health Care ETF

1.24%

ALPS Medical Breakthroughs ETF

1.07%

SPDR S&P Biotech ETF

0.42%

First Trust NASDAQ Pharmaceuticals ETF

0.37%

Invesco S&P SmallCap 600 Pure Growth ETF

0.35%

WisdomTree BioRevolution Fund

0.26%

SPDR S&P 600 Small Cap Growth ETF

0.26%

Direxion Daily S&P Biotech Bull 3X Shares

0.25%

OneAscent Small Cap Core ETF

0.25%

Vanguard S&P Small-Cap 600 Growth Index Fund

0.25%

Invesco S&P SmallCap Health Care ETF

佔比1.24%

ALPS Medical Breakthroughs ETF

佔比1.07%

SPDR S&P Biotech ETF

佔比0.42%

First Trust NASDAQ Pharmaceuticals ETF

佔比0.37%

Invesco S&P SmallCap 600 Pure Growth ETF

佔比0.35%

WisdomTree BioRevolution Fund

佔比0.26%

SPDR S&P 600 Small Cap Growth ETF

佔比0.26%

Direxion Daily S&P Biotech Bull 3X Shares

佔比0.25%

OneAscent Small Cap Core ETF

佔比0.25%

Vanguard S&P Small-Cap 600 Growth Index Fund

佔比0.25%

分紅派息



近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股



公告日期

類型

比率

暫無數據

公告日期

類型

比率

暫無數據